As these processes are deregulated during epithelial-mesenchymal transition (EMT) and contribute to the acquisition of motile and invasive phenotypes by cancer cells24, we hypothesized that CNK2 and CNK3 could be involved in regulating cell motility. The gene discussed is CNKSR3; the disease is cancer.